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Biofilm Matrixome: Extracellular Components in
Structured Microbial Communities
L. Karygianni,1,4 Z. Ren,2,4 H. Koo,2,3,5 and T. Thurnheer 1,5,*
Biofilms consist of microbial communities embedded in a 3D extracellular matrix.
The matrix is composed of a complex array of extracellular polymeric sub-
stances (EPS) that contribute to the unique attributes of biofilm lifestyle and
virulence. This ensemble of chemically and functionally diverse biomolecules is
termed the ‘matrixome’. The composition and mechanisms of EPSmatrix forma-
tion, and its role in biofilm biology, function, and microenvironment are being
revealed. This perspective article highlights recent advances about the multifac-
eted role of the ‘matrixome’ in the development, physical–chemical properties,
and virulence of biofilms. We emphasize that targeting biofilm-specific condi-
tions such as the matrixome could lead to precise and effective antibiofilm
approaches. We also discuss the limited knowledge in the context of
polymicrobial biofilms, and the need for more in-depth analyses of the EPS ma-
trix in mixed communities that are associated with many human infectious
diseases.
Introduction
Biofilm is defined as a structured community of microbial cells firmly attached to a surface and
embedded in a matrix composed of extracellular polymeric substances (EPS) (see
Glossary). The EPS consist of exopolysaccharides, nucleic acids (eDNA and eRNA [1]), proteins,
lipids, and other biomolecules. The formation of sessile biofilm communities involves highly com-
plex and dynamic events whereby EPS play key structural and functional roles that are essential
for the emergent properties of biofilms [1]. EPS promote microbial adhesion to biotic and abi-
otic surfaces. Once attached, further EPS production forms a matrix that surrounds and cements
cells together, keeping them in close proximity and allowing intercellular interactions in a confined
space [1]. The EPS matrix also provides mechanically stable and complex chemical microenvi-
ronments that are fundamental for the biofilm lifestyle [2]. Besides offering structural stability
and a functional environment, EPS also enhance biofilm tolerance to antimicrobials and immune
cells [3,4]. In this reviewwe highlight the composition and the diverse functions of biofilm EPSma-
trices, collectively termed the ‘matrixome’, and their role in virulence from model organisms. We
also bring these findings into perspective in the context of polymicrobial communities often found
in biofilms associated with infectious diseases. We hope that this article will stimulate new ques-
tions, hypotheses, and approaches that may lead to a better understanding of the biofilm matrix
and its role in biofilm-associated infections.
The Matrixome: The Composition and Functional Diversity of the EPS Matrix
Over the years, the functional role of EPS has been increasingly recognized and intimately linked
with the emergent properties of biofilms [1,5]. Biofilm studies in the field of dental medicine pro-
vide an excellent source of information about the composition and functional roles of the EPSma-
trix (Box 1). Here we use the term ‘matrixome’, adapted from ‘matrisome’ used traditionally in the
field of eukaryotic cell biology (see Box 2), to define the entire inventory of currently known biomol-
ecules, and their molecular, structural, and functional diversity, associated with biofilm assembly
Highlights
The 'matrixome' is the inventory of cur-
rently known biomolecules (polysaccha-
rides, nucleic acids, proteins, lipids, and
lipoproteins) and their molecular, struc-
tural, and functional diversity associated
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chemical and virulence attributes.
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and its physicochemical and virulence attributes [2]. The composition and structure of EPS can
vary greatly depending on the type of microorganisms, local shear stress, availability of nutri-
ents/substrates, and the host environment [1]. EPS synthesis and spatial organization also differ
between monospecies and multispecies microbial communities [5]. Thus far, a diverse array of
biomolecules has been identified (Table 1). These can be grouped into two major categories: (i)
associated with the cell surface, and (ii) secreted extracellularly (Figure 1). Some examples include
cell-associated appendages such as flagella, type IV pili, and functional amyloids that modulate
bacterial adhesion, mechanical stability, and autoimmune responses. Conversely, secreted bac-
terial exopolysaccharides, proteins, eDNA, and eRNA released extracellularly contribute with ma-
trix scaffolding and function [1,5]. Although we focus on microbially produced EPS, biomolecules
acquired from the host or surrounding environment should be included as part of the matrixome.
Host proteins and glycoproteins (e.g., the salivary proteins) were found to contribute to the matrix
scaffold and assist microbial attachment while serving as a microbial nutrient source [6]. The EPS
components have been shown to be vital for the structural and functional attributes of the biofilm,
which can be generally divided into physical and chemical properties [3].
Minerals are the result of biomineralization processes tightly regulated by the environment or bac-
teria and serve as an essential component of the EPS [7,8]. An earlier report showed that minerals
structurally support the morphogenesis of bacterial colonies in the Gram-positive bacterium Ba-
cillus subtilis [9] and inMycobacterium species [8,9]. Biogenic minerals also provide structural in-
tegrity to biofilm matrix and act as a scaffold to protect bacterial cells from shear forces and
antimicrobial agents [10]. An earlier report demonstrated the presence of CaCO3 in the matrix
of B. subtilis and Mycobacterium smegmatis biofilms, and implied the association of matrix min-
eral with other bacterial species [9]. Another mineral, namely calcite, has been linked to various
medical conditions. In particular, biofilms of Proteus mirabilis, Proteus vulgaris, and Providencia
rettgeri cause extensive catheter encrustation by calcium and magnesium minerals [7], while
the Gram-negative pathogen Pseudomonas aeruginosa generates calcite during biofilm forma-
tion [11].
Physical Properties Provided by EPS
Adhesion–cohesion, scaffolding, mechanical stability, and protection belong to the most promi-
nent EPS functions. Collective properties of biofilms, such as collective migration and spreading,
result from cell–cell interactions and allow for an effective adaptation of bacterial masses to ad-
verse environmental conditions. The role of EPS in collective biofilm properties has been
Glossary
Biofilm virulence: intrinsic
'malevolence' of a biofilm, which is the
collective attributes and factors that lead
to infection of the host at the various
attachment sites on both biotic and
abiotic surfaces to cause disease onset
and worsen disease severity.
eDNA: extracellular DNA that can be
either a result of cell lysis or actively
secreted; eDNA may interact with
different EPS components contributing
to the biofilm structural organization,
serving as a nutrient source, while
promoting protection against
antimicrobials and horizontal gene
transfer.
Emergent properties of biofilms:
novel structures, activities, and patterns
of a biofilm that are not identifiable or
predictable through the study of
planktonic bacterial cells. Emergent
properties of biofilms include surface
adhesion-cohesion, spatial organization,
physical and social interactions,
chemical heterogeneity, and increased
tolerance to antimicrobials.
EPS degradation: therapeutic
strategies that use exogenous EPS-
degrading enzymes or other agents to
disassemble the biofilm matrix. EPS
degradation can weaken the biofilm
structure to facilitatemechanical removal
and enhance the killing efficacy of
antimicrobials when applied through an
adjunctive approach.
Extracellular polymeric substances
(EPS): EPS can contain
exopolysaccharides, fibrous and
globular proteins (including extracellular
enzymes), lipids, and nucleic acids
(eDNA). These components form a
matrix that can be surface-associated,
secreted locally, or deposited on abiotic
and biotic surfaces. The EPS matrix
functions as a 'multifunctional scaffold'
that supports and protects embedded
bacteria, creates a heterogeneous
chemical and physical milieu, while also
serving as a nutrient source for resident
microbes.
Box 1. The Dental Biofilm: Clues from Ancient to Modern Times
One of the first descriptions of bacteria living in biofilms can be traced back to a letter written by Antonie van Leeuwenhoek
to the Royal Society of London in 1683 describing a vast number of microorganisms in the dental plaque of his own teeth.
Since then biofilms have been extensively studied in different disciplines in both biomedical and industrial fields. Studies
with ‘dental plaque’ have been at the forefront of microbiome and EPS analyses [91] and even in paleomicrobiology, serv-
ing as a source of information on the composition of ancient microbial and host biomolecules, including dietary compo-
nents [92]. Many clues about ecology and dynamic changes of the human microbiota were derived from oral
microbiome studies. Likewise, early work from Bernie Guggenheim and Bill Bowen in the 1960s and 1970s [93,94] re-
vealed the first insights about the presence of abundant exopolysaccharides in the plaque associated with tooth decay,
which have been confirmed using modern microscopy and spectroscopy techniques. Furthermore, the development of
confocal laser scanning microscopy (CLSM) and fluorescence in situ hybridization (FISH) for matrix analysis, combined
with in vitro multispecies systems, animal and human-based intraoral models [95,96], allowed in-depth investigations on
the microbial and EPS matrix complexity revealing new insights into the 3D structure of biofilms. Indeed, some of the first
images showing the diversity of EPS and microbiota structure and spatial organization were acquired from oral biofilms.
The field of dental biofilm research will continually provide important information about the composition, structural organi-
zation, and function of EPS and the microbiome, which may be applicable to other polymicrobial infections and environ-
mental communities.
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Table 1. Composition and Functions of Extracellular Polymeric Substances (EPS) in Biofilms from Some Model Organisms





Extracellular Adhesion, scaffolding, stability













Adhesion, cohesion, scaffolding, stability,
cell-to-cell binding, acidic microenvironment,




Adhesion, scaffolding, stability, protection
against immune response, cell-to-cell binding
Pel Extracellular/cell-associated
Adhesion, scaffolding, stability, cell-to-cell
binding, protection against antibiotics
Alginate Extracellular
Adhesion, scaffolding, water/nutrient
retention, protection against harsh
environments/immune
response/antimicrobials, stability






Forming mannan-glucan complex (MGCx),





Forming mannan-glucan complex (MGCx),




Biofilm surface layer protein
(BslA)













Cell-associated/extracellular Adhesion, cell-to-cell binding
Staphylococcal Protein A (SpA) Cell-associated/extracellular
Adhesion, cell-to-cell binding, immune
evasion
S. aureus surface protein G
(SasG)
Cell-associated/extracellular Adhesion, cell-to-cell binding
Biofilm associated protein (BAP) Extracellular
Adhesion, cell-to-cell binding, scaffolding,
stability
Phenol-soluble modulins (PSMs) Extracellular







Dextranase Extracellular EPS degradation/remodeling
P1 (also referred to as Antigen I/II) Cell-associated Adhesion, cell-to-cell binding







Type IV pilins (T4P) Cell-associated
Adhesion, scaffolding, twitching motility,
mechanosensing
Lectins (LecA/LecB) Cell-associated/extracellular Adhesion, cell-to-cell binding, stability, cytotoxin
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highlighted in previous studies [12–15]. The EPS can promote cell adhesion to solid substrates
and cohesion among bacterial cells, eventually leading to the development of structured cell clus-
ters, often termed microcolonies [5]. Most of the current knowledge has been generated using
biofilm-forming model organisms, particularly B. subtilis, Candida albicans, Escherichia coli,
Staphylococcus aureus, Streptococcus mutans, P. aeruginosa, and Vibrio cholerae. Excellent
in-depth reviews discuss in detail the composition and functional role of EPS within various ma-
trices produced by these organisms as single-species biofilms [1,3,5,16–18]. Here, we focus
on how different organisms employ unique approaches using EPS, while bringing them into the
context of mixed or polymicrobial settings whenever details are available.
The initial bacterial adhesion often involves the classic adhesin–receptor interactions (Table 1) but
also intriguing surface-scanning and sensing mechanisms, as recently shown in V. cholerae and
B. subtilis, whereby extracellular appendages such as flagella act as mechanosensors [1,19,20].
Greater details on the EPS-mediated adhesion have been elucidated in P. aeruginosa, S. mutans,
B. subtilis, and V. cholerae at the single-cell level with single polymer precision [21–29]. Moreover,
single-cell live imaging of V. cholerae biofilms revealed that the adhesion-relevant EPS protein
Bap1, secreted by the founder cells, remains substratum-bound in mature biofilms [24]. Another
V. choleraematrix protein (RbmA) has been recently shown to exhibit adhesin-like properties me-
diating surface attachment [28]. Intriguingly, initial S. mutans colonizers appear to sense adhesion
Table 1. (continued)
Class Microorganisma Name Location Function
Vibrio cholerae
Biofilm-associated protein (Bap1) Cell-associated/extracellular
Adhesion, scaffolding, hydrophobicity,
stability, protection








Cell-associated Adhesion, motility, mechanosensing












Unknown function in EPS
Functionally classified enzymes Extracellular
Metabolism of carbohydrate/amino
acid/lipid/nucleotide/energy/vitamins,
translation, transport, catabolism, folding,







Scaffolding, adhesion, cohesion, nutrient
source, DNA damage repair, gene transfer,




Glycerolipids, sphingolipids Cell-wall/extracellular Unknown
Staphylococcus
aureus
Teichoic and lipoteichoic acids Cell-associated/extracellular








Adhesion, colonization and host invasion,
activation of immune response
aAdditional details about the EPS components, including from other microbes (such as Escherichia coli) can be found in the following references [3,5,16,18–20,97–100].
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forces that externally trigger the emergent biofilm properties over a specific distance above a sub-
stratum surface through quorum sensing [29].
EPS also promotes cell–cell cohesion (including interspecies recognition) to facilitate microbial ag-
gregation and biofilm formation [1]. Other interspecies interactions depend on mechanosensors or
Trends in Microbiology
Figure 1. Composition and Functions of Biofilm Matrix in Structured Microbial Communities. Panel A depicts
confocal fluorescence images of developed cross-kingdom dental biofilms within extracellular matrix (ECM) (red); inset shows
Streptococcus mutans (green)–Candida albicans (cyan) interactions mediated by ECM (white arrows). Panel B depicts 3D
reconstructions of in vitro oral biofilms after matrix staining and confocal laser scanning microscopy (CLSM). Specifically, six-
species biofilms consisting of Streptococcus mutans, Streptococcus oralis, Actinomyces oris, Fusobacterium nucleatum,
Veillonella dispar, and Candida albicans were grown anaerobically on pellicle-coated hydroxyapatite disks. The visualization
of the treated biofilms was aided by matrix staining and CLSM using anti-DNA antibodies, streptavidin (Cy3), calcofluor,
SYPRO Ruby, and YoPro-1/Sytox. Green, bacteria; blue, exopolysaccharides; red, extracellular DNA (eDNA); yellow,
proteins. Panel C is a schematic representation of the main components of the biofilm matrix and their functions. The biofilm
matrix consists of a wide array of functional biomolecules such as exopolysaccharides (Pel, Psl, alginate, Vibrio
polysaccharide (VPS), β-glucans, α-mannans, polysaccharide intercellular adhesin (PIA), glucans/fructans, epsA-epsO,
operon-encoded exopolysaccharide), proteins (BslA, TasA, Flagellum, FnBPs, Protein A, SasG, BAP, Gtf, Ftf, Dextranase,
P1, Gbps, Type IV pilins (T4P), LecA ,LecB, Bap1, RbmA, RbmC, MshA pili, Als) nucleic acids, and lipids that organize into
an extracellular matrix. This matrix serves as a scaffold for structural support and a dynamic milieu that provides varying
chemical and physical signals to microbial communities, promoting a biofilm lifestyle.
Trends in Microbiology
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specific adhesin (protein)–receptor (saccharide) pairs. In general, the EPS-based matrix mediates
biofilm assembly as follows. (i) The EPS formed at the site of adhesion (produced on bacterial sur-
faces or secreted on the surface of attachment) form an initial polymeric matrix promoting microbial
colonization and cell clustering. (ii) Continuous EPS production in situ further expands the matrix
three-dimensionally while forming a core of EPS-enmeshed bacterial cells. (iii) This core provides a
supporting framework, facilitating the development of 3D clusters and aggregates (or
microcolonies). The transition from initial cell clustering to microcolony appears to be conserved
among different biofilm-forming model organisms, such as P. aeruginosa, B. subtilis, V. cholerae,
and S. mutans [3,16,17,21,24–29]. For instance, S. mutans relies on EPS-producing exoenzymes,
termed glucosyltransferases (Gtfs), which synthesize glucans in situ using host diet sugars as sub-
strates [5,30]. Interestingly, Gtfs bind on the surface of many oral microbes (e.g., Actinomyces
viscosus, Lactobacillus casei, andC. albicans), even those that do not synthesize Gtfs [5], promoting
interspecies and interkingdom coadhesion [31]. Recently, a key role for EPS-protein TasA, pro-
duced by B. subtilis, in mediating interspecies aggregation with streptococci was highlighted [32].
The structural importance of EPS in ecological interactions in mixed communities was shown
using an individual-based multispecies biofilm model in which EPS-producing microbes that build
aggregates have a competitive advantage over the non-EPS-producing microbes during initial
adhesion [33].
The EPS production in situ leads to the formation of complex polymeric 3D matrix scaffolds incor-
porating a plethora of densely packedmicrobes and providing cohesion, mechanical stability in the
resulting highly compartmentalized biofilms [16]. Recent reports elucidated the scaffolding role of
highly stable networks of amyloid-insoluble aggregates comprising an assembly of protein mono-
mers in a variety of bacterial biofilms (as reviewed elsewhere [34]). For example, the nonattached
P1 adhesin (AgI/II) of S. mutans [35], the nonamyloidogenic TasA formed by Bacillus sp. [36], the
Fap fibers in Pseudomonas sp. [37], and the Bap fibers of S. aureus [38] were found to form func-
tional amyloids (amyloid-like fibers) enhancing the structural stability of biofilms and providing pro-
tection for the bacteria. Recently, structured illumination super-resolutionmicroscopy also revealed
coordinated explosive cell lysis of a specific subpopulation of P. aeruginosa that releases eDNA
and other polymers to help build-up the matrix [39], while confocal fluorescence microscopy
Box 2. Dynamic Cell–Matrix Interactions in 3D Tissue Microenvironments
Extensive research in cell and developmental biology established that eukaryotic cells sense both physical and chemical cues in
their extracellular matrix (termed ECM), which triggers cellular responses that regulate cellular functions, including remodeling
their surrounding 3D matrix. This reciprocal, bidirectional, and highly dynamic interaction between cells and matrix affects all
facets of cell biology and pathology by modulating tissue and organ morphogenesis, homeostasis, and tumorigenesis. Local
eukaryotic tissue microenvironments differ substantially in molecular composition, density, porosity, stiffness, and other fea-
tures. Similar dynamic cell–matrix interactions andmicroenvironment heterogeneity occur in biofilms, wheremicrobial cells such
as bacteria and fungi adhere and generate a surrounding EPSmatrix. Thus, relevant concepts concerning eukaryotic cell–ma-
trix interactions, despite some fundamental differences, could be applied to enhance understanding of the biofilm developmen-
tal biology and expression of virulence. The eukaryotic ECM has well characterized functions as a chemical reservoir of growth
factors, cytokines, and proteases, and the ECM can limit the diffusive range, accessibility, and concentrations of signaling li-
gands, providing spatial, chemical, andmechanical cues to activate intracellular signaling cascades. For example,matrix glyco-
proteins and proteoglycans can enhance signaling and adhesive functions, while growth factors and cytokines incorporated
within ECM can locally stimulate adherent cells. Conversely, the mechanical characteristics of ECM, such as rigidity, porosity,
and cross-linking, can be sensed by eukaryotic cells throughmechanotransduction, affecting proliferation and gene expression
locally. Matrix stiffness can alter differentiation, signaling, and induce tumorigenesis.Within tumors, there are often local regions
of hypoxia, acidic pH, and the release of proteases and other cellular constituents. During tumor metastasis, cancer cells can
invade or disperse to distant sites through complex processes of local matrix or target-tissue microenvironmental remodeling.
Conceptually, similar processes appear to exist during biofilm development and dispersal. The biofilm EPS matrix provides
highly structured yet spatially and chemically heterogeneous environments that locally affect cellular physiology, transcriptional
activity, and survival that, albeit described, still needs furthermechanistic elucidation. Advances in eukaryotic matrix biology and
cell–matrix interactions can help to stimulate new questions and insights to the field of biofilm biology, which in turn may also
provide new approaches for tissue engineering and cancer biology.
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enabled the visualization of specific colocalized EPS components and interactions between Pel
and eDNAwithin P. aeruginosa biofilms [40]. However, the contribution of individual matrix compo-
nents to emergent physical properties of multispecies-species biofilms remains poorly understood.
As biofilm becomes established, an essential physical feature of EPS is to provide physical stability
and resistance to mechanical removal, antimicrobials, and host immunity. EPS-associated visco-
elasticity of mature biofilms (afforded by exopolysaccharides and eDNA) makes their detachment
from the substratum challenging even under sustained fluid shear stress or high mechanical pres-
sure [17]. Interestingly, increased EPS production also reflects a highly adaptive/protective re-
sponse of biofilms to environmental stress factors such as high shear as revealed by attenuated
total reflection Fourier transform infrared (ATR-FTIR) spectroscopy combined with tribometry [41].
In addition to mechanical resistance, EPS also promote protection against antimicrobials and en-
hanced drug tolerance [1,16–18,35,38–40]. EPS can act as a diffusion-limiting barrier against various
antimicrobials resulting in limited drug access into the deeper layers of the biofilm [42]. Retarded pen-
etration due to the reaction of antimicrobials with EPS components, (e.g., positively charged agents
likely bind to negatively charged polymers) also contributes to the antimicrobial tolerance of biofilms
[4], enabling inactivation or degradation of antimicrobials by enzymes present in biofilmmatrix [43]. In-
teraction of antimicrobials with biofilmmatrix can also alter specific genetic determinants of antimicro-
bial tolerance. Recently, an intriguing interkingdom EPS-mediated antimicrobial resistance was found
inmixed-species biofilms containingC. albicans and bacteria. Exopolysaccharides (β-1,3-glucan cell-
wall component) secreted by C. albicans prevented penetration of antibacterial drugs (such as van-
comycin) providing enhanced antimicrobial protection for S. aureus within mixed biofilms [44,45].
Conversely,S.mutans glucans surroundingCandida cells directly bound and sequestered an antifun-
gal agent (fluconazole), reducing drug uptake and enhancing C. albicans tolerance within mixed
biofilms [46]. Similarly, a three-species (P. aeruginosa, S. aureus, and C. albicans) interkingdom bio-
film yielded resistance to flucloxacillin, ciprofloxacin, or fluconazole. This can be presumably attributed
to the diffusion-limiting effects of EPS-matrix or the presence of EPS-associated degradative en-
zymes [47,48]. Yet, the exact mechanisms of the EPS-mediated resistance of biofilms to antibiotics
have not been elucidated. Another example is the biofilm formed by Bacillus sp. which presents as
a highly hydrophobic community that resists wetting by water, solvents, and biocides by forming a
hydrophobic film that coats the biofilm surface and renders it water-repellent. This remarkable prop-
erty is conferred by the secreted BslA and orthologous proteins that can self-assemble into an orga-
nized lattice at the water–air interface [49,50].
However, it is important to keep in mind that biofilm formation may be essential for some benefi-
cial functions. B. subtilis, for example, has gained interest for its probiotic properties as it can ef-
fectively maintain a favorable balance of microflora in the gastrointestinal tract. In order to survive
processing and storage of food, as well as passage through the upper gastrointestinal tract,
B. subtilis produces an extracellular matrix that protects it from stressful environments [51]. In ad-
dition, B. subtilis can effectively protect plants against diverse microbial threats. The protein ma-
trix component TasA and the exopolysaccharide have both been shown to be essential for
effective plant-root colonization in both Arabidopsis and tomato plants [16].
Chemical Properties Associated with EPS Such compartmentalized architecture confers cohe-
sive yet highly heterogeneous environments within a 3Dmatrix scaffold. EPS as a physical bound-
ary can sequester or trap diverse substances while also influencing the diffusion of various
molecules inside the biofilm, thereby creating nutritional and chemical gradients, including oxy-
gen, pH, signaling molecules, inorganic ions, metabolites, and other solutes, across the biofilm
3D architecture. As a result, heterogeneous biofilm microenvironments with varying chemical
Trends in Microbiology
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milieus ensue, which can be further altered by the interactions between EPS and local microbial
metabolism [52,53]. Localized oxygen heterogeneity within B. subtilis biofilms modulated the
function of the matrix protein BslA by inducing redox-dependent bifunctionality. Specifically,
BslA presented as a dimer on the exposed oxygen-rich biofilm surface, whereas in deeper anoxic
biofilm layers BslA dimerization was inhibited, triggering nutrient uptake [49]. Further studies on
P. aeruginosa and E. coli biofilms underlined the differential EPS-related gene expression and
metabolic specialization between microbial subpopulations with varied oxygen abundance
[54,55]. For instance, in the absence of the redox-dependent cytochrome bd-expressing sub-
population (responsible for aerobic respiration under hypoxic conditions) in E. coli biofilms during
acute urinary tract infections, substantially less EPSwas produced [55]. Extracellular pHmicroen-
vironments have been spatially assessed using noninvasive in situ pHmeasurement via multipho-
ton confocal microscopy showing a highly heterogeneous pH distribution across intact 3D biofilm
architecture [56–58]. At a single-microcolony level, the EPSmatrix allowed a gradient of acidic mi-
croenvironments to form that directly regulated the differential expression of pH-responsive atpB
by S. mutans distributed across various locations throughout the biofilm structure [56].
Another prominent chemical function of the biofilm matrix is its role as local nutrient reservoir of
various biomolecules, for example, fermentable polysaccharides [2,16,59]. A recent report re-
vealed that due to osmotic pressure differences in V. cholerae biofilms, the microbial colonies
physically swell, thereby maximizing their contact with nutritious surfaces and thus, nutrient up-
take [60]. Consistent with this finding, nutrient availability in dual-species (C. albicans/Streptococ-
cus oralis) biofilms seems to promote biofilm expansion without interfering with its mechanical
stability [61]. Notably, the biofilm matrix can also act as an external digestion system due to the
immobilization of exoenzymes which actively participate in EPS remodeling (synthesis and degra-
dation) and metabolism of diverse substrates [5]. In S. mutans biofilms, dextranase and
fructanase directly degrade EPS components, for example soluble glucans and fructans, respec-
tively, allowing for the production of fermentable polysaccharides on-site that can be utilized dur-
ing starvation [5]. The eDNA is considered as a carbon source that can influence biofilm dispersal
[62]. Interestingly, anionic EPS components and eDNA can serve as cation chelators and even
generate a cation-deficient environment, thereby promoting antimicrobial resistance [63]. How-
ever, the role of othermatrix components in nutrient deposition and the formation of chemical gra-
dients over time needs further elucidation, especially in polymicrobial biofilms.
Biofilms contain a variety of heterogenous, EPS-delineated milieus able to alter local gene expres-
sion, metabolic activity, and importantly intercellular signaling between different species within the
biofilm mass [2,3,64–66]. Recent analyses of pathways modulating biofilm matrix gene expression
have revealed a plethora of extra- and intracellular signaling molecules [67]. Quorum sensing (QS)
is highly associated with matrix, thereby affecting biofilm functions. In P. aeruginosa biofilms,
exopolysaccharides facilitate the absorption of QSmolecules within the biofilm, whereas biofilm ma-
trix can either activate or deactivate QS processes [68]. Nevertheless, the detailed pathways by
which matrix regulates chemical or mechanical sensing/signaling remain unknown for both single-
and multispecies biofilms.
The Matrixome: Amplifying the Biofilm Virulence
The physical and chemical properties of the biofilmmatrix provide emergent properties of the biofilms
that are critical for biofilm existence and expression of virulence. These include adhesion–cohesion,
pathological microenvironments, mechanical and drug resistance that can lead to disease onset
and worsen disease severity. Here, we focus on host infection animal models reporting the potential
role of EPS in biofilm virulence. However, we realize that this is a nascent field in polymicrobial set-
tings and that there is a very limited number of studies investigating in vivo.
Trends in Microbiology
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Matrix-Associated Biofilm Virulence
The importance of the matrix in collective microbial behavior and function, as well as for toler-
ance of antimicrobials, is being increasingly recognized and considered integral to biofilm viru-
lence [1,3–5,16–18,69]. The matrix plays an essential role in the pathogenesis of human and
animal diseases as several matrix constituents are recognized as potential virulence factors
[1–5,16,17,70]. Staphylococcal EPS – for example, eDNA and poly-N-acetylglucosamine sur-
face polysaccharide (PNAG) –mediate numerous virulence traits, including host colonization and
antimicrobial resistance. Activation of PNAG production in S. aureus not only contributed to biofilm
formation on the surface of implanted catheters [71] but also slowed down neutrophil recruitment
and bacterial clearance in mice challenged intraperitoneally with S. epidermidis biofilm cells of a
PNAG-defective mutant [72]. Biofilm-producing strains of P. aeruginosa are a major cause of mor-
bidity and mortality in cystic fibrosis (CF) patients. In an animal model, increased levels of Th2 cy-
tokines and macrophages were primarily EPS-driven rather than by the pathogen P. aeruginosa
itself [73].
The secretion of proteases and other extracellular enzymes, such as lipase, esterase, DNase,
RNase, and fibrinolysin, is an essential process for bacterial growth and virulence. For instance,
bacterial glycosyltransferases and their EPS glucan products have been extensively studied for
their functional roles in the pathogenesis of dental caries (tooth decay) in in vivo and clinical stud-
ies [5,74]. Glucans promote bacterial adhesion–cohesion, interspecies interactions, and biofilm
accumulation as well as helping to create protective and highly acidic microenvironments
[5,74]. Recently, a putative glucosyltransferase in S. mutans (SMU_833) was found to modulate
dynamic interactions between two key biofilm matrix components, glucan and eDNA. The dele-
tion of smu_833 decreases glucan and increases eDNA but maintains the overall biofilm biomass
with reduced virulence in an in vivo rat model of dental caries [75]. Dextranase (Dex) is a type of
glucanase of S. mutans, participating in the modification and degradation of extracellular
water-soluble glucans, which has been associated with caries development in rats [76].
Bacterial pathogens, such as P. aeruginosa and S. aureus, have developed a complex network of
evasion, counter-inhibition, and subjugation in their battle for space and nutrients. Notably, EPS
components also play an important role for interspecies interactions between these organisms
in vivo [25]. The assembly of enteric biofilm is essential to understand the role of EPS virulence.
The EPS of enteric biofilms –mainly including amyloid curli, eDNA, O antigen, cellulose, and sur-
face proteins such as BapA – are etiologically associated with the autoimmune disease lupus er-
ythematosus (SLE) and can activate the fibrillization of the Parkinson’s disease-related amyloid α-
synuclein [77]. Enteric EPS components have long been recognized as pathogen-associated
molecular patterns (PAMPs) that can activate proinflammatory innate immune receptors, such
as Toll-like receptors (TLR2, TLR9), CD14 heterocomplex, and NLRP3. Curli are extracellular am-
yloid fibers produced by enterobacteria such as E. coli and Salmonella. These fibers have been
shown to play an important role in biofilm formation as they display direct interaction with the sub-
stratum and form bundles between bacterial cells, thus allowing a cohesive and stable associa-
tion of cells in the biofilm. Curli have been found to not only protect E. coli but to enhance its
virulence potential by blocking the actions of C1q [34,78,79].Other protein fibers, often described
as functional amyloid or amyloid-like fibers – for example the Fap fibers in Pseudomonas sp., the
nonamyloidogenic TasA fibers formed by B. subtilis, and the Bap fibers of S. aureus – are also
commonly present in bacterial biofilms. Their structural/functional importance and link to biofilm
virulence has been reviewed extensively elsewhere [34]. However, it is important to note that
there is great diversity in composition of the amyloid fibers formed by a broad range of species;
this needs further elucidation, especially in how they contribute to the biofilm virulence collectively
in a polymicrobial community.
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In C. albicans, the most common opportunistic fungal pathogen, multiple matrix components
(e.g., extracellular polysaccharides such as β-glucans and mannan) have been associated
with virulence. These matrix components can protect C. albicans from antifungal drugs
and host immune systems [18,80]. Using an in vivo venous catheter biofilm model,
C. albicans biofilms were shown to impair neutrophil response through an inhibitory pathway
induced by EPS [81]. Moreover, Candida spp. are frequently implicated in mixed bacterial-
fungal infections forming biofilms that cause many infections in humans, particularly mucosal
diseases [82]. Candida-derived β-glucans and extracellular enzymes such as phospholi-
pases, lipases, and hemolysins have been associated with infections of the bloodstream, im-
plant, vagina, and oral cavity [83]. C. albicans virulence has also been associated with eDNA
and extracellular vesicles carrying several virulence factors that were found to stimulate im-
mune responses in macrophages and dendritic cells [84]. In addition to mucosal infections,
C. albicans also appears to interact with S. mutans on tooth surfaces, forming mixed-
kingdom biofilms associated with severe early childhood caries. Such interactions modify
the biofilm environment by boosting the amounts of both bacterial and fungal-derived EPS,
increasing the biofilm mass, density of infection, and acidogenicity, leading to enhanced
caries severity in vivo [31,45,46].
Combating the Matrixome via Multitargeted Strategies
Themultifaceted nature of biofilmmatrixome imposes great challenges to combat biofilm-related dis-
eases. Due to the complex physical and biological properties of EPS matrix, biofilm infections are
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Figure 2. Therapeutic Strategies Targeting the Biofilm Matrix. The matrix is a multifunctional scaffold that is essential for the entire biofilm's life cycle, from initial
microbial colonization to biofilm maturation, and expression of virulence. Biofilms are not amenable to conventional antimicrobial approaches due to the complex physical
and biological properties of the matrix. Targeting the matrix, especially the extracellular polymeric substances (EPS) elements that are universal among different species
(e.g., exopolysaccharides, proteins, and eDNA) may have the potential to achieve cross-species antibiofilm efficacy in a polymicrobial infection. Therapeutic strategies can
be designed to prevent the biofilm formation either by inhibiting EPS production or blocking adhesin-mediated adherence (left). When biofilms are already established,
strategies that can degrade EPS macromolecules may dismantle the scaffolding/protective matrix to weaken the biofilm structure and potentiate antimicrobial killing
(middle). In cases where biofilm removal is favorable, and aggressive measures are needed (e.g., dental hygiene and surgical debridement of infection sites), the EPS
network can also be disrupted using physical-mechanical methods.
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often not amenable to conventional antimicrobial approaches, requiring multitargeted or combinato-
rial therapies. Current and prospective therapeutic strategies targeting the vital structural and func-
tional traits in EPS have been recently reviewed [4,85]. However, knowledge about EPS-targeting
approaches has been derived mostly from single-species biofilms, and studies using polymicrobial
systems remain sparse.
In general, targeting can be achieved by inhibiting the production of EPS, blocking adhesin-
mediated adherence and/or by degrading EPS in established biofilms (Figure 2; see also
Table S1 in the supplemental information online). Biofilm EPS production is regulated by several
extracellular/intracellular signaling networks and nonsignaling mechanisms, which can be
targeted to control biofilm formation [2,3,66,86]. Blocking EPS-mediated adherence via inhibitors
of adhesin production or adhesin-bindingmolecules targets EPS–host interaction to prevent bac-
terial and fungal biofilm initiation. However, manymicroorganisms exhibit multiple receptor–ligand
interactions that allow binding to host surfaces. Therefore, more than a single adhesive process
must be impeded for the bacterial colonization to be blocked, which requires better knowledge of
the biology and stereochemistry of adhesins [60]. The extracellular nucleoproteins (DNABII family)
that provide structural integrity to eDNA were also targeted using antibodies, resulting in destabi-
lization of the biofilm structure. Targeting DNABII showed in vivo efficacy in various biofilms found
in oral, urinary tract, and pulmonary infections, indicating its therapeutic potential in polymicrobial
infections [87–89]. Interestingly, antiamyloid drugs originally designed to target human patho-
logical amyloids (e.g., in Alzheimer’s and Parkinson’s diseases) were repurposed as novel
antibiofilm agents, inspired by the recent finding of the conserved fibrillar architecture be-
tween bacterial and human amyloids [79]. When biofilms pre-exist with a substantial amount
of matrix already formed, strategies that inhibit EPS synthesis or block the adhesion interac-
tions may not be successful due to the presence of established and protective microenviron-
ments [4]. In this case, it may be necessary to degrade the formed EPS using enzymes and
other agents to disrupt the physical integrity of the matrix, and facilitate biofilm disruption
and removal [4]. For maximal efficacy, EPS-degrading enzymes can be used as adjunctive
agents for conventional antimicrobials that enhance drug penetrability and microbial killing
activity, while promoting breakdown of the biofilm structure [69,90]. In addition, physical
removal, including mechanical, energy-based and light-based disruption, may further
improve EPS-based intervention strategies [4].
New technologies and bio/nanomaterials could provide alternative ways to control EPS-mediated
biofilm virulence. For example, on-demand 'smart release' nanocarriers that can penetrate
biofilms and be triggered by pathogenic microenvironments to deliver drugs or multifunctional
compounds (from catalytic nanoparticles to aptamers, dendrimers, and bioactive peptides)
have been developed to disrupt the EPS and the viability or metabolic activity of the embedded
bacteria. The use of probiotics or phage therapy targeting EPS has also been considered as
potential antibiofilm strategies. Nevertheless, questions remain on the efficacy of solely targeting
EPS as it may not necessarily address bacterial viability. Given the complexity of biofilm biology,
therapeutic strategies that target both the microorganisms and the EPSmatrix – to either prevent
biofilm initiation or disrupt existing biofilms – appear to be a more effective and precise approach.
Future Directions and Perspectives
The biofilmmatrix is more than a scaffold to maintain the biofilm structure. EPS participates actively
in functional properties that are essential for biofilm assembly, persistence, collective behavior, and
virulence, such as signaling, genetic exchange, creation of microenvironments, mechanical stabil-
ity, and antimicrobial tolerance.Moreover, matrix is being constantly formed and remodeled, affect-
ing structure and function throughout the biofilm's life cycle.
Outstanding Questions
How does the dynamic EPS synthesis
and degradation (remodeling) influ-
ence the physicochemical properties
of the matrix, microbial signaling, and
communal behavior within the biofilm?
What are the roles of nucleic acids
(eDNA, ribosomal DNA, and eRNA)
and eDNA–protein or eDNA–
polysaccharide complexes found in
the biofilm matrix?
How does the bacterial phenotypic
and genomic heterogeneity affect
EPS matrix assembly and biofilm
development?
How do the physicochemical properties
of the matrix modulate the development
of microenvironments and pathogenic
niches in polymicrobial biofilm
communities?
How does the microenvironment
heterogeneity impact interspecies or
interkingdom interactions and virulence
of polymicrobial biofilms?
Trends in Microbiology
678 Trends in Microbiology, August 2020, Vol. 28, No. 8
It is noteworthy that biofilms constantly restructure, and the microenvironment dynamically
changes, whereas most of the data available have been gathered in observations taken at individ-
ual points in time or in static conditions. Therefore, further investigations should focus on the dy-
namics of regulation of matrix formation, structural organization, and remodeling, which may lead
to new insights into the composition and structure of EPS in biofilms. These can be facilitated
using recent technological advances in time-lapse super-resolution imaging and in situ
spectroscopy-based methods combined with computational analyses. Furthermore, real-time
metabolite profiling combined with new labeling methods using pH/O2-sensitive fluorescent
probes cross-linked to different EPS components may reveal the spatiotemporal dynamics of mi-
croenvironments developing at different locations throughout the biofilm architecture.
However, the presence of different species, and even different kingdoms, further complicates
compositional analyses and biological properties of EPS. While more details of the EPS matrix
composition in polymicrobial biofilms are being revealed, the knowledge about its functional
role and structural organization – as well as mechanistic details on how different microbes collec-
tively regulate production and interact with the EPS components within intact biofilms – remains
limited. We emphasize the need for the development of robust and reproducible polymicrobial
biofilms using laboratory and in vivo models to help assess the functional role of the various
types of EPS from different organisms in a mixed community.
Enhanced understanding of the multifaceted nature of biofilm matrix can also lead to more effica-
cious approaches to control biofilm-related diseases. Variability of the EPS composition and
structure – depending on the microbial species and metabolic activity, nutrient availability, host en-
vironment, and growth stage – poses significant hurdles to the development of EPS-targeting ther-
apeutics. Conventional approaches focused solely on EPS degradation (or antimicrobial activity)
may not achieve efficacy within the complex (physicochemical) biofilm microenvironment. Prospec-
tive therapeutic strategies need to target simultaneously the biofilm matrix components and the em-
bedded microorganisms to eradicate the pathogenic niche with minimal cytotoxicity to surrounding
tissues. A potential way to enhance precision and efficacy may involve ‘stimuli-triggered bioactivity/
drug delivery’ or ‘on-demand activation’ in response to biofilm-specific conditions, including EPS
production, bacterial activity, and chemical environment (such as pH and O2) in addition to en-
hanced drug penetration. However, rigorous assessment of efficacy, feasibility, and biocompatibil-
ity of novel approaches is required using clinically relevant in vivo models, which remain
underdeveloped. Future studies addressing current limitationsmay lead to breakthroughs in biofilm
basic research and clinical translation of prospective therapeutics (see Outstanding Questions).
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